Brief: Autolus Therapeutics To Receive $70 Million In Milestone Payments From Blackstone Life Sciences
08/12/2022 21:52
Dec 8 (Reuters) - Autolus Therapeutics PLC AUTL.O :
* AUTOLUS THERAPEUTICS TO RECEIVE $70 MILLION IN MILESTONE
PAYMENTS FROM BLACKSTONE LIFE SCIENCES
* AUTOLUS THERAPEUTICS - DEVELOPMENT MILESTONE OF $35M
ACHIEVED
EARLIER THAN ANTICIPATED AS A RESULT OF POSITIVE INTERIM
ANALYSIS OF FELIX PHASE 2 TRIAL
Source text for Eikon: ID:nGNX9JxBsQ
Further company coverage: AUTL.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Autolus Therapeutics
See all newsBrief: Autolus Therapeutics PLC Unit Enters Master Service Agreement With AGC Biologics
Brief: Autolus Therapeutics Appoints Ryan Richardson To Board Of Directors
Brief: Nice Recommends Aucatzyl As A Treatment Option For Adult Patients With Lymphoblastic Leukemia
Brief: Autolus Therapeutics’ Car T Therapy Aucatzyl® (Obecabtagene Autoleucel) Granted European Marketing Authorization For Adult Patients
Brief: Autolus Therapeutics Announces Inducement Grants